Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Pfizer Trump Drug Prices: A Landmark Deal for A...
By
Rene Pretorius
October 1, 2025
Summary President Trump announced that Pfizer has agreed to lower drug prices. This is part of a broader initiative to reduce prescription d...
PhRMA’s Patient Access Investment: $500 Billion Commitment to Domestic ...
Sanofi Insulin Savings: Your Comprehensive Guide for 2025
Transforming Cancer Treatment: Implications of Subcutaneous Pembrolizumab App...
CAPVAXIVE Pneumococcal Vaccine Delivers Strong Immune Response in At-Risk Youth
New Federal Actions to Combat Misleading Prescription Drug Ads in 2025
Medicare ACO Outcomes: Balancing Surgical Benefits and Costs Under the TEAM M...
Impact of Generic Liraglutide Launch on Weight Management and Health Economics
Collaboration Cardiac Surgery: Boosting Surgical Volumes Through Multidiscipl...
FDA Guidance on Overall Survival Assessment in Oncology Trials
Eli Lilly’s Innovation Statement: Advocating Drug Pricing Reforms
Strengthening the U.S. Pharmaceutical Supply Chain: Establishing a Strategic ...
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
« Previous
1
2
3
4
…
11
Next »